Bioblast Pharma Ltd. (ORPN) dipped -8.97% or -0.2 to $2.03. It is around 67329 shares traded, which is 27.53% compare to the average total volume 244610. The market cap of ORPN is $6.79 million. The year to date change is -896.45%. The 52 week price range is from $1.49 to $5.99. Price of ORPN have changed -1.33% during last week. It have changed -7.08% over last month, -27.36% over last 3 months, 13.20% over last 6 months and 1.36% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 2.21. It is 8.87% above current price. The 200-day Moving Averages for ORPN is 2.42. It is 19.21% above current price. The 52-week High is 5.99. It is 195.07% from the current price. The 52-week Low is 1.49. It is -26.60% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ORPN is 0.47 on 2018-05-31. Short % to float is 4.65%. There are some statistics of ORPN. It is has market cap $6.79 million. The share outstanding is 3.34 million. The average volume is 244610. The percent of top 15 Institution holding is 6.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -90.86%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -75.50%.